MRSN icon

Mersana Therapeutics
MRSN

Overview Fund Activity

48 hedge funds and large institutions have $70M invested in Mersana Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
9
Increased
12
Reduced
15
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$2.24M
2
JG
2
Jefferies Group
New York
$1.37M
3
ACH
3
ArrowMark Colorado Holdings
Colorado
$8.27M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$1.73M
5
HP
5
Hikari Power
Japan
$348K

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$3.94M
2
EC
2
EcoR1 Capital
California
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.09M
4
Millennium Management
4
Millennium Management
New York
$181K
5
BlackRock
5
BlackRock
New York
$3.19M
Name Holding Trade Value Shares
Change 		Shares
Change %
American Century Companies
51
American Century Companies
Missouri
– -$113K -451 Closed
ProShare Advisors
52
ProShare Advisors
Maryland
– -$110K -439 Closed
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
– -$2K -10 Closed
Daiwa Securities Group
54
Daiwa Securities Group
Japan
– -$1K -5 Closed
1 2
3